Cas:747371-90-0 (3R)-4-Amino-3-(4-fluorophenyl)butanoic acid manufacturer & supplier

Chemical Name:(3R)-4-Amino-3-(4-fluorophenyl)butanoic acid

CAS.NO:747371-90-0

Synonyms:(3S)-4-Amino-3-(4-fluorophenyl)butanoic acid;(3R)-4-Amino-3-(4-fluorophenyl)butanoic acid;MFCD11520155;(s)-4-amino-3-(4-fluorophenyl)butanoic acid;Benzenepropanoic acid, β-(aminomethyl)-4-fluoro-, (βS)-;Benzenepropanoic acid, β-(aminomethyl)-4-fluoro-, (βR)-

Molecular Formula:C₁₀H₁₂FNO₂

Molecular Weight:197.206

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:329.1±32.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.546

PSA:

Exact Mass:197.085205

LogP:1.02

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (3S)-4-Amino-3-(4-fluorophenyl)butanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzenepropanoic acid, β-(aminomethyl)-4-fluoro-, (βR)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD11520155 Use and application,Benzenepropanoic acid, β-(aminomethyl)-4-fluoro-, (βS)- technical grade,usp/ep/jp grade.

Related News: The findings were published June 14 in the journal Nature Aging. (3R)-4-Amino-3-(4-fluorophenyl)butanoic acid manufacturer Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders. (3R)-4-Amino-3-(4-fluorophenyl)butanoic acid supplier The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries. (3R)-4-Amino-3-(4-fluorophenyl)butanoic acid vendor The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses. (3R)-4-Amino-3-(4-fluorophenyl)butanoic acid factory Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.